13 March 2022
The world's largest genetic study of people with severe COVID has identified DNA variations that could lead to new life-saving treatments for the disease.
The story I wish to share with readers today is identified in the title to the piece and perhaps of more interest and meaning to the MHMS and medical professionals than to everyone, but nevertheless an indication of the kind of breakthrough all those having to try and save lives from Covid disease will welcome.
Reuters has reported today, Sunday, research has identified 16 changes to the DNA sequence of critically ill COVID patients that affected their immune response, or increased the risk of blood clotting and inflammation in the lungs.
Quote.
The researchers in the GenOMICC consortium, which involved almost every intensive care unit in the UK, say the findings map out new molecular targets for drugs that are currently used to treat other medical conditions.
Professor Kenneth Baillie, the study's chief investigator and a critical care consultant at the University of Edinburgh, said: "We have shown for the first time in the history of critical care medicine that an infectious disease that causes organ failure is treatable by supressing the immune system.
"That's reason to carrying on trying to treat COVID better and get the mortality down to zero. That should be what we are aiming for."
The researchers compared the complete genetic sequence of almost 7,500 critically ill patients with more than 48,000 people from Genomics England's database who had not had COVID, and a further 1,630 who had mild symptoms.
The Omicron variant has brought new challenges to the world
Results published in the journal Nature showed 16 variations were far more common in people who suffered a bad outcome from the disease.
'Absolutely extraordinary'
An earlier study by the same researchers identified four genetic targets for treatment.
As a result, baricitinib, an anti-inflammatory drug normally used to treat rheumatoid arthritis, was tested as part of the NHS-run RECOVERY trial, with results showing that it saved lives.
"When we started this study we were funded by a small charity founded by a group of relatives of a patient who died in intensive care and they generously supported us to get started," Prof Baillie said.
"I said to them this could take more than 10 or 15 years to go from finding genes to having an impact on therapy.
"So to do it in little over a year is absolutely extraordinary."
The human genetic code, or genome, is three billion letters long. But single substitutions with a different letter in key genes can change the blueprint for making proteins.
One of the newly discovered variations was in a gene that makes interferon, a molecule used by cells to signal to the immune system that there is an infection present. Because the protein was folded in a slightly different way cells were unable to raise the alarm.
Effective therapies
"This was significantly associated with the chances of dying with COVID," said Prof Baillie.
The study has been so successful at identifying drug targets that the scientists are now tackling other major causes of mortality in critically ill patients, including sepsis, or blood poisoning, in which the immune system over-reacts to an infection and attacks body organs.
More than 120 treatments for sepsis have been tested in trials over the last four decades but without success.
Prof Baillie said: "GenOMICC has shown we can find effective therapies for critical illness using genetics.
"Emboldened by that demonstration of the concept we will work as hard as we can. Our 10-year aim to have a clinical impact on sepsis, but it might take longer than that."
Comment
I hope in sharing this published research information it will be of some help and guidance to the MHMS and a source of information that might help the Solomon Islands medical authorities in dealing with critical illness.
Sources – Reuters and MSM (UK)
Yours sincerely
Frank Short
